跳至主要内容
临床试验/KCT0003211
KCT0003211已完成未知

Efficacy and Safety of Lactobacillus acidophilus YT1 Probiotics on menopausal symptoms; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Korea Food Research Institute0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 60(Year)(—)
性别
Female

入选标准

  • 1)40 to 60 year-old women with FSH 30 mIU / ml or more who have passed one year since the last menstrual period or who have no uterus
  • 2) Women with a kupperman index score of 20 or higher
  • 3) Women who have agreed to participate in this human body test before the start of the human body test and who have written an informed consent

排除标准

  • 1) Women with a body mass index (BMI) greater than 30 kg / m2
  • 2) Women using hormone preparations such as female hormones or similar hormone preparations (plant extracts, etc.) within 3 months
  • 3) Women with a history of endometrial hyperplasia, uterine cancer, endometrial cancer, breast cancer or breast disease, sex hormone related cancer
  • 4) A woman with a history of severe migraine within the past year or who has been diagnosed with thromboembolism, cerebrovascular disease, myocardial infarction, unstable angina, or underwent coronary angioplasty
  • 5) Women with severe mental illnesses such as depression and anxiety disorder, or those currently taking psychotropic drugs such as antidepressants
  • 6) Women with irregular uterine bleeding after 1 year of menopause
  • 7) Patients with uncontrolled hypertension (160 /100mmHg or more, After 10 minutes of stabilization)
  • 8) Uncontrolled diabetes mellitus patients (fasting blood sugar more than 180mg/dL or starting a new drug due to diabetes within 3 months)
  • 9) Patients with thyroid disease whose TSH is less than or equal to 0.1 µU / ml or more than 10 µU / ml
  • 10) drug or alcohol abuser
  • 11) If ALT or AST exceeds 3 times the normal upper limit of the research institute
  • 12) Creatinine exceeds twice the normal upper limit of research institute
  • 13) Mammography / PAP smear When a clinically significant abnormality (BI-RADS Category 0 or 3 or more, PAP smear is absent up to ASCUS) is confirmed
  • 14) Have participated or planned to participate in other clinical trials within the past month
  • 15) If the tester judges that the test is inappropriate for this human body test
  • 16) Women using thyroid hormone preparations, clonidine, anticoagulants or antithrombotic agents (Warfarin, Clipidogrel, etc.) within 3 months
  • 17) Women who took medicines or health functional foods related to women's menopause within a month
  • 18) Women who have taken probiotics within 2 weeks of screening
  • 19) Those taking or administering a therapeutic agent for osteoporosis, such as a bisphosphonate preparation

研究者

相似试验